Earnings Call · Q3 FY2022·2022-11-01

Q3 22EPS -3.57%·Rev n/aQ2 22EPS -5.62%·Rev n/aQ1 22EPS -49.15%·Rev n/aQ4 21EPS -95.45%·Rev n/a⚠ consensus missing

NEUROCRINE BIOSCIENCES INC NBIX

Todd Tushla — Investor Relations or Call Moderator

Kevin Gorman — Chief Executive Officer

Matt Abernethy — Chief Financial Officer

Eric Benevich — Chief Commercial Officer

Eiry Roberts — Chief Medical Officer

+3.7%1d on move date+4.1% vs SPY3d+7.8%5d+5.2%

Research tier

Behavioral profile computed for 5 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more NBIX calls or request research access.

More NBIX calls Browse calls Request research access